文献速递区域麻醉与超声

罗哌卡因浓度对固定剂量腓总神经阻滞时长的影响:健康志愿者随机双盲试验

The effect of ropivacaine concentration on common peroneal nerve block duration using a fixed dose: A randomised, double-blind trial in healthy volunteers.
PubMed 文献 · Eur J Anaesthesiol · 2020-01-01

本研究在健康志愿者中采用固定剂量10 mg罗哌卡因、不同稀释体积(2.5–20 ml)行超声引导腓总神经阻滞,发现感觉阻滞时长无显著差异(P=0.073),但运动阻滞时长随浓度降低而缩短(P=0.002),提示稀释可缩短运动阻滞。

要点

  • 固定10 mg罗哌卡因下,改变浓度不影响感觉阻滞时长。
  • 罗哌卡因稀释可缩短运动阻滞时长(P=0.002)。
  • 临床或可通过稀释罗哌卡因选择性缩短运动阻滞。

核心结论

  • 与假设相反,改变罗哌卡因浓度未影响平均感觉阻滞时长,但稀释降低了运动阻滞时长。

研究设计与样本

  • 随机双盲试验,单中心学术医院,健康志愿者。
  • 每组分配固定10 mg罗哌卡因溶于2.5、5、10、15或20 ml 0.9%氯化钠,对应浓度4、2、1、0.67、0.5 mg/ml。

主要发现

  • 所有受试者均出现感觉阻滞,60名中56名出现运动阻滞。
  • 从最高到最低浓度组,感觉阻滞平均±SD时长分别为13.1±2.7、13.4±3.3、12.6±3.9、10.4±2.9、11.0±2.1 h(P=0.073)。
  • 从最高到最低浓度组,运动阻滞平均±SD时长分别为8.5±2.0、7.9±3.0、6.1±3.1、5.9±3.5、4.0±1.9 h(P=0.002)。

关键数值与推荐

  • 主要结局为感觉阻滞时长,定义为对冷刺激敏感度改变或消失。
  • 次要结局为运动阻滞时长,定义为轻瘫或瘫痪。
  • 组间差异采用单因素方差分析检验。

临床怎么用

  • 在固定低剂量罗哌卡因下,稀释浓度可缩短运动阻滞而不明显改变感觉阻滞。
  • 临床可据此调整罗哌卡因稀释度以平衡感觉与运动阻滞需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The effect of local anaesthetic concentration on peripheral nerve block duration is unclear. Recent clinical trials found nerve blocks of equivalent duration despite changing local anaesthetic concentration but with a fixed local anaesthetic dose. A criticism of these studies is that the local anaesthetic doses used were above the proposed local anaesthetic dose-duration ceiling level, masking any potential effect of different local anaesthetic concentrations on nerve block duration. OBJECTIVE: We investigated the effect of local anaesthetic concentration on nerve block duration using a fixed local anaesthetic dose below the local anaesthetic dose-duration ceiling level. We hypothesised that changing local anaesthetic concentration would affect nerve block duration. DESIGN: Randomised, double-blind trial. SETTING: Single-centre, academic hospital. PARTICIPANTS: Healthy volunteers. INTERVENTIONS: Each participant received an ultrasound-guided common peroneal nerve block with a fixed dose of 10 mg of ropivacaine dissolved in either 2.5, 5, 10, 15 or 20 ml of 0.9% saline according to group allocation, yielding local anaesthetic concentrations of 4, 2, 1, 0.67 and 0.5 mg ml. MAIN OUTCOME MEASURES: The primary outcome was duration of sensory block defined as altered or no sensitivity to a cold stimulus. The secondary outcome was duration of motor block defined as either paresis or paralysis. Intergroup differences were tested using one-way Analysis of variance . RESULTS: All participants had sensory block, and 56 out of 60 participants had motor block. From the highest to the lowest concentration groups, mean ± SD sensory block durations were 13.1 ± 2.7, 13.4 ± 3.3, 12.6 ± 3.9, 10.4 ± 2.9 and 11.0 ± 2.1 h (P = 0.073), and mean ± SD motor block durations were 8.5 ± 2.0, 7.9 ± 3.0, 6.1 ± 3.1, 5.9 ± 3.5, 4.0 1.9 h (P = 0.002). CONCLUSION: In contrast to our hypothesis, we found no changes in mean sensory nerve block duration. However, local anaesthetic dilution resulted in reduced motor block duration. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03326609.

来源:Eur J Anaesthesiol,查看原文。版权归原作者所有。

引用

  1. Christiansen CB, Madsen MH, Mølleskov E, et al. The effect of ropivacaine concentration on common peroneal nerve block duration using a fixed dose: A randomised, double-blind trial in healthy volunteers. Eur J Anaesthesiol. 2020. PMID: 31789898. doi:10.1097/EJA.0000000000001112

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。